Plesner

Jeppe Brinck-Jensen advises on IP law, primarily patent and trademark law, marketing law and design law. He also has special expertise in drafting licence agreements, technology transfers and research and development agreements.

Jeppe is involved in litigation before the Danish courts as well as in arbitration proceedings and has conducted a large number of IP cases before the Danish Maritime and Commercial High Court, the Danish High Courts and the Danish Supreme Court.

He has particular expertise in advising the pharmaceutical industry.

Highlights

• Astra Zeneca vs Krka (esomeprazole) - Patent for Nexium®
• Gilead vs Accord and others - (tenofivir dispoproxil + emtricitabine) - SPC for Truvada® og Atripla®
• Novartis vs Orifarm Generics - (rivastigmine) - Patent for Exelon®
• Mirrx Therapeutics vs Santaris Pharma A/S - right to invention - use of trade secrets
• Merck vs Orifarm - (montelukast) - parallel import - Trademark for Nuvaring®
• Merck vs Orifarm - specific mechanism - SPC for Singulair®
• Clear Channel Danmark vs AFA JCDecaux  - copyright to bus shelter

Professional Activities and Experience

• 2019 Chambers Global
• 2019 Legal 500
• 2016 2017 2018 2019 IP Star
• 2018 iam1000
• 2018 WTR 1000
• 2018 Chambers Global
• 2017 Chambers Global
• 2017 Whoswho
• 2017 iam1000
• 2016 Chambers Global
• 2016 iam1000
• 2015 Chambers Global
• 2015 iam1000
• 2014 Legal 500